The training program of GlySign is well balanced between a broad inter-sectoral education and individual specialization which will result in independent PhDs with excellent employability due to a broad set of skills around a recognizable core expertise. They will be uniquely suited to pioneer the translation of glycosylation biomarkers in clinical and technological research groups in academia, spin-offs, SME and big pharma.
The training is structured around a training-by-research approach which is enriched by the inter-sectoral experience provided to each early stage researcher (ESR) and by focused secondments at partner organizations. Our trans-European network incorporates a long-standing and fruitful collaboration between leading academic and industrial partners from the fields of glycomics and glycoproteomics technology and clinical glycomics and glycoproteomics. Education will be rounded up by basic scientific courses, transferable-skills workshops, network-wide events and active participation in (inter)national conferences. The 6 ESRs will therefore achieve excellent employability further strengthened by training in business development, IP management, rules & regulations for clinical research and medical diagnostics, self-management and multiple aspects of communication. The ESRs will enrich the global scientific community and enhance the competitive position of European Industry, by delivering both knowledge and products with high impact.
In conclusion, the GlySign network will train 6 ESRs in cutting-edge research in biomarker validation and translation, focused on glycosylation signatures and multiomics markers.